troglitazone has been researched along with cycloheximide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleck, E; Goetze, S; Gotlibowski, T; Hsueh, WA; Kawano, H; Law, RE; Xi, XP | 1 |
| Leff, T; Su, TZ; Wang, M; Wise, SC | 1 |
| Hayashi, T; Hosoda, K; Inoue, G; Inoue, R; Masuzaki, H; Nakao, K; Nishimura, H; Ogawa, Y; Shintani, M; Yamamoto, Y; Yonemitsu, S | 1 |
| Brunmair, B; Fürnsinn, C; Gras, F; Neschen, S; Roden, M; Wagner, L; Waldhäusl, W | 1 |
| Hsueh, WA; Kim, S; Kintscher, U; Kuroki, T; Law, RE; Liu, Z; Ohba, M; Schönthal, AH; Wakino, S; Yin, F | 1 |
| Bae, MA; Song, BJ | 1 |
| Inoue, H; Miwa, Y; Miyagi, M; Morimoto, S; Sasaguri, T; Taba, Y; Takahashi-Yanaga, F | 1 |
| Clark, OH; Duh, QY; Hyun, WC; Lobo, M; Park, JW; Wong, MG | 1 |
| Cheon, H; Choi, SJ; Ji, JD; Kim, HJ; Lee, YH; Rho, YH; Sohn, J; Song, GG; Um, JW | 1 |
| Bertin, I; Dauça, M; Domenjoud, L; Fiatte, C; Huin, C; Lesuffleur, T; Plénat, F; Pluvinet, A; Schohn, H; Touche, N | 1 |
| Ha, ES; Hahn, JH; Jeoung, D; Kang, D; Kim, BC; Kim, DJ; Kim, HD; Kim, MK; Kim, YK; Lee, KJ; Lee, SH; Park, JH; Park, KH; Suh, JS | 1 |
11 other study(ies) available for troglitazone and cycloheximide
| Article | Year |
|---|---|
PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
Topics: Animals; Aorta, Thoracic; Calcium-Calmodulin-Dependent Protein Kinases; Cell Movement; Cells, Cultured; Chemotactic Factors; Chromans; Cycloheximide; Dactinomycin; Enzyme Activation; Insulin-Like Growth Factor I; Ligands; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Prostaglandin D2; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Thrombin; Transcription Factors; Troglitazone | 1999 |
Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
Topics: 3T3 Cells; Animals; Anticholesteremic Agents; Cell Line; CHO Cells; Cholesterol; Chromans; Cricetinae; Cycloheximide; Dactinomycin; Hypoglycemic Agents; Mice; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Receptors, Cytoplasmic and Nuclear; RNA; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 1999 |
Troglitazone induces GLUT4 translocation in L6 myotubes.
Topics: Animals; Biological Transport; Cell Line; Cell Membrane; Chromans; Cycloheximide; Deoxyglucose; Gene Expression Regulation; Glucose Transporter Type 1; Glucose Transporter Type 3; Glucose Transporter Type 4; Insulin; Kinetics; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Nerve Tissue Proteins; Protein Transport; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Troglitazone | 2001 |
Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression.
Topics: Animals; Chromans; Cycloheximide; Dactinomycin; Drug Interactions; Energy Metabolism; Gene Expression; In Vitro Techniques; Insulin Resistance; Ligands; Male; Muscle, Skeletal; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone | 2001 |
Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells.
Topics: Acetophenones; Adenoviridae; Animals; Aorta, Thoracic; Apoptosis; Benzopyrans; Blotting, Western; Carbazoles; Cell Division; Cells, Cultured; Chromans; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cycloheximide; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Hydroquinones; Indoles; Insulin; Isoenzymes; Kinetics; Ligands; Mice; Mitogens; Models, Biological; Muscle, Smooth, Vascular; Phosphorylation; Platelet-Derived Growth Factor; Precipitin Tests; Protein Kinase C; Protein Kinase C-delta; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; RNA; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone; Tyrosine; Up-Regulation; Vanadates | 2001 |
Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Carrier Proteins; Chromans; Cycloheximide; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone; Tumor Cells, Cultured | 2003 |
15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells.
Topics: Apoptosis; Blotting, Western; Caspase 3; Caspases; Cell Nucleus; Cells, Cultured; Chromans; Cycloheximide; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Humans; Hypoglycemic Agents; Immunologic Factors; Inhibitor of Apoptosis Proteins; Intramolecular Oxidoreductases; Lipocalins; Luciferases; Microtubule-Associated Proteins; Neoplasm Proteins; Prostaglandin D2; Protein Biosynthesis; Protein Synthesis Inhibitors; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stress, Mechanical; Survivin; Thiazoles; Thiazolidinediones; Troglitazone; Ubiquitin-Protein Ligases; Umbilical Veins | 2003 |
Modulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by chemotherapy in thyroid cancer cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell Line, Tumor; Chromans; Cycloheximide; Drug Synergism; Humans; Membrane Glycoproteins; Paclitaxel; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Thiazolidinediones; Thyroid Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Troglitazone; Tumor Necrosis Factor-alpha | 2003 |
15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
Topics: Arthritis, Rheumatoid; Chromans; Cycloheximide; Dactinomycin; DNA-Binding Proteins; Gene Expression Regulation; Humans; Hypoglycemic Agents; Interleukin-6; Jurkat Cells; Lymphocytes; NF-kappa B; Phosphorylation; PPAR gamma; Prostaglandin D2; Protein Synthesis Inhibitors; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Thiazolidinediones; Trans-Activators; Troglitazone | 2005 |
Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
Topics: Base Sequence; Caco-2 Cells; Chromans; Chromosome Mapping; Colonic Neoplasms; Cycloheximide; Dactinomycin; Exons; HCT116 Cells; HT29 Cells; Humans; Pioglitazone; PPAR gamma; Protein Isoforms; RNA, Messenger; Thiazolidinediones; Troglitazone; Untranslated Regions | 2006 |
CD36 signaling inhibits the translation of heat shock protein 70 induced by oxidized low density lipoprotein through activation of peroxisome proliferators-activated receptor gamma.
Topics: CD36 Antigens; Cell Line, Tumor; Chromans; Cycloheximide; HSP70 Heat-Shock Proteins; Humans; Lipoproteins, LDL; Monocytes; PPAR gamma; Protein Synthesis Inhibitors; Signal Transduction; Thiazolidinediones; Troglitazone | 2008 |